MiniMed Group is trading 4.36% up at $22.97 as U.S. growth stocks gain ahead of the Federal Reserve’s September 16 decision.

  • Nasdaq is up 0.90% and the S&P 500 is up 0.46%, supporting risk appetite.
  • No fresh company-specific announcement clearly explains the move.
  • The active Medtronic exchange-offer process remains relevant background, but its September 14 filing predates today’s rally.